Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Care | Research

Health care consequences of hospitalization with Clostrioides difficile infection: a propensity score matching study

Authors: Bruce E. Hirsch, Myia S. Williams, Dimitre G. Stefanov, Martin L. Lesser, Karalyn Pappas, Thomas Iglio, Craig Gordon, Renee Pekmezaris

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

Clostridiodies difficile infection (CDI) has been characterized by the Center for Disease Control and Prevention (CDC) as an urgent public health threat and a major concern in hospital, outpatient and extended-care facilities worldwide.

Methods

A retrospective cohort study of patients aged ≥ 18 hospitalized with CDI in New York State (NYS) between January 1, 2014–December 31, 2016. Data were extracted from NY Statewide Planning and Research Cooperative (SPARCS) and propensity score matching was performed to achieve comparability of the CDI (exposure) and non-CDI (non-exposure) groups. Of the 3,714,486 hospitalizations, 28,874 incidence CDI cases were successfully matched to 28,874 non-exposures.

Results

The matched pairs comparison demonstrated that CDI cases were more likely to be readmitted to the hospital at 30 (28.26% vs. 19.46%), 60 (37.65% vs. 26.02%), 90 (42.93% vs. 30.43) and 120 days (46.47% vs. 33.74), had greater mortality rates at 7 (3.68% vs. 2.0%) and 180 days (20.54% vs. 11.96%), with significant increases in length of stay and total hospital charges (p < .001, respectively).

Conclusions

CDI is associated with a large burden on patients and health care systems, significantly increasing hospital utilization, costs and mortality.
Literature
1.
go back to reference Prevention C for DC and. Biggest Threats and Data | Antibiotic/Antimicrobial Resistance | CDC. Prevention C for DC and. Biggest Threats and Data | Antibiotic/Antimicrobial Resistance | CDC.
2.
go back to reference Guh AY, Kutty PK. Clostridioides difficile infection. Annal Intern Med. 2018;169:49–62. Guh AY, Kutty PK. Clostridioides difficile infection. Annal Intern Med. 2018;169:49–62.
3.
go back to reference Marra AR, Perencevich EN, Nelson RE, Samore M, Khader K, Chiang HY, et al. Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(1):e1917597.CrossRef Marra AR, Perencevich EN, Nelson RE, Samore M, Khader K, Chiang HY, et al. Incidence and outcomes associated with Clostridium difficile infections: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(1):e1917597.CrossRef
4.
go back to reference Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect. 2012;18:5–12.CrossRef Bouza E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect. 2012;18:5–12.CrossRef
5.
go back to reference Wilkins T, Sequoia J, Jennings W, Dorn B. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Phys. 2017;96:170–8. Wilkins T, Sequoia J, Jennings W, Dorn B. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Phys. 2017;96:170–8.
6.
go back to reference Kwon J, Olsen M, Dubberke E. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123–34.CrossRef Kwon J, Olsen M, Dubberke E. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123–34.CrossRef
7.
go back to reference Olsen MA, Stwalley D, Demont C, Dubberke ER. Clostridium difficile infection increases acute and chronic morbidity and mortality. Infect Control Hosp Epidemiol. 2019;40(1):65–71.CrossRef Olsen MA, Stwalley D, Demont C, Dubberke ER. Clostridium difficile infection increases acute and chronic morbidity and mortality. Infect Control Hosp Epidemiol. 2019;40(1):65–71.CrossRef
8.
go back to reference Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;26(9):825–34.CrossRef Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;26(9):825–34.CrossRef
11.
go back to reference Gould CV, File TM, McDonald LC. Causes, burden, and prevention of Clostridium difficile infection. Infect Dis Clin Pract. 2015;23:281–8.CrossRef Gould CV, File TM, McDonald LC. Causes, burden, and prevention of Clostridium difficile infection. Infect Dis Clin Pract. 2015;23:281–8.CrossRef
12.
go back to reference Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterol Rep. 2018;6(1):21.CrossRef Hopkins RJ, Wilson RB. Treatment of recurrent Clostridium difficile colitis: a narrative review. Gastroenterol Rep. 2018;6(1):21.CrossRef
13.
go back to reference Office of Quality and Patient Safety. New York State Report on Quality, Patient Safety, and Efficiency Division of Information and Statistics. 2016. Office of Quality and Patient Safety. New York State Report on Quality, Patient Safety, and Efficiency Division of Information and Statistics. 2016.
14.
go back to reference Mathews SN, Lamm R, Yang J, Park J, Tzimas D, Buscaglia JM, et al. Factors associated with health care utilization of recurrent Clostridium difficile infection in New York State. J Clin Gastroenterol. 2019;53(4):298–303.CrossRef Mathews SN, Lamm R, Yang J, Park J, Tzimas D, Buscaglia JM, et al. Factors associated with health care utilization of recurrent Clostridium difficile infection in New York State. J Clin Gastroenterol. 2019;53(4):298–303.CrossRef
15.
go back to reference Normand SLT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–98.CrossRef Normand SLT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387–98.CrossRef
16.
go back to reference Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107.CrossRef Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–107.CrossRef
17.
go back to reference Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3–4):169–88.CrossRef Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3–4):169–88.CrossRef
18.
go back to reference Prescott HC, Dickson RP, Rogers MAM, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015;192(5):581–8.CrossRef Prescott HC, Dickson RP, Rogers MAM, Langa KM, Iwashyna TJ. Hospitalization type and subsequent severe sepsis. Am J Respir Crit Care Med. 2015;192(5):581–8.CrossRef
20.
go back to reference Krive J, Patel M, Gehm L, Mackey M, Kulstad E, Li JJ, et al. The complexity and challenges of the ICD-9-CM to ICD-10-CM transition in emergency departments. Am J Emerg Med. 2015;33(5):713.CrossRef Krive J, Patel M, Gehm L, Mackey M, Kulstad E, Li JJ, et al. The complexity and challenges of the ICD-9-CM to ICD-10-CM transition in emergency departments. Am J Emerg Med. 2015;33(5):713.CrossRef
21.
go back to reference Shaffer SR, Nugent Z, Bernstein CN, Walkty A, Singh H. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study. BMC Gastroenterol. 2022;22(1):140.CrossRef Shaffer SR, Nugent Z, Bernstein CN, Walkty A, Singh H. Effect of clinical versus administrative data definitions on the epidemiology of C. difficile among hospitalized individuals with IBD: a population-based cohort study. BMC Gastroenterol. 2022;22(1):140.CrossRef
22.
go back to reference Nelson RE, Nelson SD, Khader K, Perencevich EL, Schweizer ML, Rubin MA, et al. The magnitude of time-dependent bias in the estimation of excess length of stay attributable to healthcare-associated infections. Infect Control Hosp Epidemiol. 2015;36(9):1089–94.CrossRef Nelson RE, Nelson SD, Khader K, Perencevich EL, Schweizer ML, Rubin MA, et al. The magnitude of time-dependent bias in the estimation of excess length of stay attributable to healthcare-associated infections. Infect Control Hosp Epidemiol. 2015;36(9):1089–94.CrossRef
Metadata
Title
Health care consequences of hospitalization with Clostrioides difficile infection: a propensity score matching study
Authors
Bruce E. Hirsch
Myia S. Williams
Dimitre G. Stefanov
Martin L. Lesser
Karalyn Pappas
Thomas Iglio
Craig Gordon
Renee Pekmezaris
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Care
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07594-x

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.